Comparative Transcriptome Analysis Identifies Desmoglein-3 as a Potential Oncogene in Oral Cancer Cells
Author:
Wan Hong1ORCID, Teh Muy-Teck1ORCID, Mastroianni Giulia2, Ahmad Usama Sharif1
Affiliation:
1. Center for Immunobiology and Regenerative Medicine, Institute of Dentistry, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London E1 2AT, UK 2. School of Biological and Behavioural Sciences, Faculty of Science and Engineering, Queen Mary University of London, London E1 4NS, UK
Abstract
The role of desmoglein-3 (DSG3) in oncogenesis is unclear. This study aimed to uncover molecular mechanisms through comparative transcriptome analysis in oral cancer cells, defining potential key genes and associated biological processes related to DSG3 expression. Four mRNA libraries of oral squamous carcinoma H413 cell lines were sequenced, and 599 candidate genes exhibited differential expression between DSG3-overexpressing and matched control lines, with 12 genes highly significantly differentially expressed, including 9 upregulated and 3 downregulated. Genes with known implications in cancer, such as MMP-13, KRT84, OLFM4, GJA1, AMOT and ADAMTS1, were strongly linked to DSG3 overexpression. Gene ontology analysis indicated that the DSG3-associated candidate gene products participate in crucial cellular processes such as junction assembly, focal adhesion, extracellular matrix formation, intermediate filament organisation and keratinocyte differentiation. Validation of RNA-Seq was performed through RT-qPCR, Western blotting and immunofluorescence analyses. Furthermore, using transmission electron microscopy, we meticulously examined desmosome morphology and revealed a slightly immature desmosome structure in DSG3-overexpressing cells compared to controls. No changes in desmosome frequency and diameter were observed between the two conditions. This study underscores intricate and multifaceted alterations associated with DSG3 in oral squamous carcinoma cells, implying a potential oncogenic role of this gene in biological processes that enable cell communication, motility and survival.
Reference44 articles.
1. Chen, Y.J., Lee, L.Y., Chao, Y.K., Chang, J.T., Lu, Y.C., Li, H.F., Chiu, C.C., Li, Y.C., Li, Y.L., and Chiou, J.F. (2013). DSG3 facilitates cancer cell growth and invasion through the DSG3-plakoglobin-TCF/LEF-Myc/cyclin D1/MMP signaling pathway. PLoS ONE, 8. 2. Desmoglein 3: A help or a hindrance in cancer progression?;Brown;Cancers,2015 3. Desmoglein 3 Silencing Inhibits Inflammation and Goblet Cell Mucin Secretion in a Mouse Model of Chronic Rhinosinusitis via Disruption of the Wnt/beta-Catenin Signaling Pathway;Cheng;Inflammation,2019 4. Activation of WNT family expression and signaling in squamous cell carcinomas of the oral cavity;Uraguchi;J. Dent. Res.,2004 5. Tsang, S.M., Liu, L., The, M.T., Wheeler, A., Grose, R., Hart, I.R., Garrod, D.R., Fortune, F., and Wan, H. (2010). Desmoglein 3, via an interaction with E-cadherin, is associated with activation of Src. PLoS ONE, 5.
|
|